BOQI International Medical Stock Forecast, Price & News

-0.01 (-0.70 %)
(As of 06/16/2021 10:13 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume400 shs
Average Volume976,341 shs
Market Capitalization$34.73 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BIMI News and Ratings via Email

Sign-up to receive the latest news and ratings for BOQI International Medical and its competitors with MarketBeat's FREE daily newsletter.

About BOQI International Medical

BOQI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. It offers prescription and over-the-counter drugs, nutritional supplements, health foods, and sundry products, as well as traditional Chinese medicines, personal and family care products, and miscellaneous items under the Lijiantang Pharmacy brand name. The company also provides IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as NF Energy Saving Corporation and changed its name to BOQI International Medical Inc. in December 2019. BOQI International Medical Inc. was incorporated in 2000 and is based in Dalian, the People's Republic of China.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.40 out of 5 stars

Medical Sector

1814th out of 2,100 stocks

Miscellaneous Fabricated Metal Products Industry

15th out of 18 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

BOQI International Medical (NASDAQ:BIMI) Frequently Asked Questions

What stocks does MarketBeat like better than BOQI International Medical?

Wall Street analysts have given BOQI International Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BOQI International Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BOQI International Medical?

BOQI International Medical saw a drop in short interest in May. As of May 28th, there was short interest totaling 36,400 shares, a drop of 36.8% from the May 13th total of 57,600 shares. Based on an average trading volume of 421,900 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.2% of the shares of the stock are sold short.
View BOQI International Medical's Short Interest

When is BOQI International Medical's next earnings date?

BOQI International Medical is scheduled to release its next quarterly earnings announcement on Monday, October 18th 2021.
View our earnings forecast for BOQI International Medical

How has BOQI International Medical's stock price been impacted by Coronavirus?

BOQI International Medical's stock was trading at $3.48 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BIMI shares have decreased by 59.5% and is now trading at $1.41.
View which stocks have been most impacted by COVID-19

Who are BOQI International Medical's key executives?

BOQI International Medical's management team includes the following people:
  • Mr. Tiewei Song, CEO, Pres & Director (Age 50)
  • Mr. Jun Jia, Chief Financial Officer (Age 33, Pay $114k)
  • Mr. Xiaoping Wang, Chief Operating Officer (Age 41)

Who are some of BOQI International Medical's key competitors?

What other stocks do shareholders of BOQI International Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BOQI International Medical investors own include iBio (IBIO), Airgain (AIRG), AIM ImmunoTech (AIM), Aytu Biopharma (AYTU), Nuwellis (CHFS), Clovis Oncology (CLVS), (COCP), Inovio Pharmaceuticals (INO), Inpixon (INPX) and Lianluo Smart (LLIT).

What is BOQI International Medical's stock symbol?

BOQI International Medical trades on the NASDAQ under the ticker symbol "BIMI."

Who are BOQI International Medical's major shareholders?

BOQI International Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Citadel Advisors LLC (0.66%), HRT Financial LP (0.35%) and UBS Group AG (0.10%).

Which major investors are buying BOQI International Medical stock?

BIMI stock was purchased by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, HRT Financial LP, and UBS Group AG.

How do I buy shares of BOQI International Medical?

Shares of BIMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BOQI International Medical's stock price today?

One share of BIMI stock can currently be purchased for approximately $1.41.

How much money does BOQI International Medical make?

BOQI International Medical has a market capitalization of $34.73 million and generates $12.85 million in revenue each year.

How many employees does BOQI International Medical have?

BOQI International Medical employs 222 workers across the globe.

What is BOQI International Medical's official website?

The official website for BOQI International Medical is

Where are BOQI International Medical's headquarters?

BOQI International Medical is headquartered at ROOM 3601 BUILDING A HARBOUR VIEW PL NO 2 WUWU ROAD ZHONGSHAN DISTRICT DALIAN, DALIAN F4, 116000.

How can I contact BOQI International Medical?

BOQI International Medical's mailing address is ROOM 3601 BUILDING A HARBOUR VIEW PL NO 2 WUWU ROAD ZHONGSHAN DISTRICT DALIAN, DALIAN F4, 116000. The company can be reached via phone at 8604-11-8220-9211 or via email at [email protected]

This page was last updated on 6/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.